Almanack Investment Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Almanack Investment Partners's LLY Position: Q1 2026 in Review
Almanack Investment Partners increased its Eli Lilly (LLY) stake by 7.7% in Q1 2026, buying an estimated $24.3K and bringing the position to 337 shares worth $310K. The position accounts for 0.05% of the portfolio, ranked #128.
Almanack Investment Partners first reported a position in LLY in Q2 2020 and has held it in 19 quarters since. The position peaked at $1.31M in Q3 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Almanack Investment Partners held 337 shares of Eli Lilly worth $310K as of Q1 2026.
- Almanack Investment Partners bought 24 Eli Lilly shares in Q1 2026, an estimated $24.3K.
- Eli Lilly made up 0.05% of Almanack Investment Partners's portfolio in Q1 2026, its #128 holding.
- Almanack Investment Partners first reported a position in Eli Lilly in Q2 2020 and has held it in 19 quarters since.
- Almanack Investment Partners's Eli Lilly position peaked at $1.31M in Q3 2023.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Almanack Investment Partners's 13F filing for Q1 2026, filed 5 May 2026.